Details of the Drug

General Information of Drug (ID: DM3PZLM)

Drug Name

NGR-hTNF

Synonyms

Arenegyr; NGR-hTNF (solid tumors); Tumor necrosis factor therapy (recombinant protein), MolMed; CD13 TNF-alpha conjugate (solid tumors), MolMed; NGR-hTNF (solid tumors), MolMed; Vascular-targeted TNF (NGR-TNF), MolMed SpA; Vascular-targeted TNF (solid tumors, iv/infusion/biological therapeutic), MolMed

Indication

Disease Entry	ICD 11	Status	REF
Colorectal cancer	2B91.Z	Phase 3	[1]
Malignant pleural mesothelioma	2C26.0	Phase 3	[2]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D08GIH

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027311)
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)